Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2003 1
2004 1
2005 2
2006 1
2007 2
2008 3
2009 1
2011 2
2012 4
2013 3
2014 3
2015 4
2016 3
2017 1
2019 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

30 results
Results by year
Filters applied: . Clear all
Page 1
DNA methylation inhibitors in cancer: recent and future approaches.
Gros C, Fahy J, Halby L, Dufau I, Erdmann A, Gregoire JM, Ausseil F, Vispé S, Arimondo PB. Gros C, et al. Among authors: ausseil f. Biochimie. 2012 Nov;94(11):2280-96. doi: 10.1016/j.biochi.2012.07.025. Epub 2012 Aug 11. Biochimie. 2012. PMID: 22967704 Review.
Proteasome inhibitors from Neoboutonia melleri.
Long C, Beck J, Cantagrel F, Marcourt L, Vendier L, David B, Plisson F, Derguini F, Vandenberghe I, Aussagues Y, Ausseil F, Lavaud C, Sautel F, Massiot G. Long C, et al. Among authors: ausseil f. J Nat Prod. 2012 Jan 27;75(1):34-47. doi: 10.1021/np200441h. Epub 2011 Dec 14. J Nat Prod. 2012. PMID: 22168134
Parthenolide inhibits tubulin carboxypeptidase activity.
Fonrose X, Ausseil F, Soleilhac E, Masson V, David B, Pouny I, Cintrat JC, Rousseau B, Barette C, Massiot G, Lafanechère L. Fonrose X, et al. Among authors: ausseil f. Cancer Res. 2007 Apr 1;67(7):3371-8. doi: 10.1158/0008-5472.CAN-06-3732. Cancer Res. 2007. PMID: 17409447
Semisynthetic neoboutomellerone derivatives as ubiquitin-proteasome pathway inhibitors.
Beck J, Guminski Y, Long C, Marcourt L, Derguini F, Plisson F, Grondin A, Vandenberghe I, Vispé S, Brel V, Aussagues Y, Ausseil F, Arimondo PB, Massiot G, Sautel F, Cantagrel F. Beck J, et al. Among authors: ausseil f. Bioorg Med Chem. 2012 Jan 15;20(2):819-31. doi: 10.1016/j.bmc.2011.11.066. Epub 2011 Dec 8. Bioorg Med Chem. 2012. PMID: 22206869
Bioactive flavonoids of Tanacetum parthenium revisited.
Long C, Sauleau P, David B, Lavaud C, Cassabois V, Ausseil F, Massiot G. Long C, et al. Among authors: ausseil f. Phytochemistry. 2003 Sep;64(2):567-9. doi: 10.1016/s0031-9422(03)00208-5. Phytochemistry. 2003. PMID: 12943776
Design and synthesis of new non nucleoside inhibitors of DNMT3A.
Erdmann A, Menon Y, Gros C, Molinier N, Novosad N, Samson A, Gregoire JM, Long C, Ausseil F, Halby L, Arimondo PB. Erdmann A, et al. Among authors: ausseil f. Bioorg Med Chem. 2015 Sep 1;23(17):5946-53. doi: 10.1016/j.bmc.2015.06.066. Epub 2015 Jul 10. Bioorg Med Chem. 2015. PMID: 26220519
Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells.
Zwergel C, Schnekenburger M, Sarno F, Battistelli C, Manara MC, Stazi G, Mazzone R, Fioravanti R, Gros C, Ausseil F, Florean C, Nebbioso A, Strippoli R, Ushijima T, Scotlandi K, Tripodi M, Arimondo PB, Altucci L, Diederich M, Mai A, Valente S. Zwergel C, et al. Among authors: ausseil f. Clin Epigenetics. 2022 Sep 28;14(1):119. doi: 10.1186/s13148-022-01339-y. Clin Epigenetics. 2022. PMID: 36171618 Free PMC article. No abstract available.
New insights on the mechanism of quinoline-based DNA Methyltransferase inhibitors.
Gros C, Fleury L, Nahoum V, Faux C, Valente S, Labella D, Cantagrel F, Rilova E, Bouhlel MA, David-Cordonnier MH, Dufau I, Ausseil F, Mai A, Mourey L, Lacroix L, Arimondo PB. Gros C, et al. Among authors: ausseil f. J Biol Chem. 2015 Mar 6;290(10):6293-302. doi: 10.1074/jbc.M114.594671. Epub 2014 Dec 18. J Biol Chem. 2015. PMID: 25525263 Free PMC article.
Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells.
Zwergel C, Schnekenburger M, Sarno F, Battistelli C, Manara MC, Stazi G, Mazzone R, Fioravanti R, Gros C, Ausseil F, Florean C, Nebbioso A, Strippoli R, Ushijima T, Scotlandi K, Tripodi M, Arimondo PB, Altucci L, Diederich M, Mai A, Valente S. Zwergel C, et al. Among authors: ausseil f. Clin Epigenetics. 2019 May 6;11(1):68. doi: 10.1186/s13148-019-0663-8. Clin Epigenetics. 2019. PMID: 31060628 Free PMC article.
30 results